As a de novo mucin in pancreatic cancer, MUC5AC could be detected as early as the pre-malignant/dysplastic stages [35], and was identified in a high percentage of PDAC [34, 36–37]. Here, MUC5AC is linked to familial pancreatic carcinoma.